Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TTEQ | 30.41 | 0.17 | +0.56% |
| T. Rowe Price Technology ETF | |||
| ASEA | 17.15 | 0.08 | +0.45% |
| Global X FTSE Southeast Asia ETF | |||
| FPXE | 31.67 | 0.04 | +0.13% |
| First Trust IPOX Europe Equity Opps ETF | |||
| GLO | 5.48 | N/A | N/A |
| Clough Global Opportunities Fund | |||
| YMAX | 13.16 | N/A | N/A |
| YieldMax Universe Fund Of Option Inc ETF | |||
A.I.dvisor indicates that over the last year, ASPHF has been loosely correlated with NERV. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ASPHF jumps, then NERV could also see price increases.
| Ticker / NAME | Correlation To ASPHF | 1D Price Change % | ||
|---|---|---|---|---|
| ASPHF | 100% | N/A | ||
| NERV - ASPHF | 44% Loosely correlated | -1.98% | ||
| GPCR - ASPHF | 31% Poorly correlated | +0.68% | ||
| NURPF - ASPHF | 30% Poorly correlated | N/A | ||
| PYPD - ASPHF | 24% Poorly correlated | +0.31% | ||
| GOSS - ASPHF | 24% Poorly correlated | +1.15% | ||
More | ||||